Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 38
Filter
Add more filters










Publication year range
1.
Eksp Klin Farmakol ; 67(3): 18-20, 2004.
Article in Russian | MEDLINE | ID: mdl-15341061

ABSTRACT

The investigation of electrophysiological parameters of the cardiac activity in cats showed that, a derivative of lidocaine with glutamic acid (anion), does not influence the cardiac pacemaker and the myocardial excitability of atrium and ventricles, but decreases the atrioventricular conduction and increases the refractory period of myocardium in the left ventricle of intact heart. Under the conditions of myocardial ischemia, LKhT-3-00 exhibits a negative chronotropic effect. Lidocaine glutamate increases the refractory period of atrium and decreases the excitability and refractory period of ventricles.


Subject(s)
Anti-Arrhythmia Agents/pharmacology , Lidocaine/analogs & derivatives , Lidocaine/pharmacology , Animals , Arrhythmias, Cardiac/etiology , Arrhythmias, Cardiac/physiopathology , Arrhythmias, Cardiac/prevention & control , Cats , Electrocardiography , Female , Heart Conduction System/drug effects , Male , Myocardial Ischemia/complications , Myocardial Ischemia/physiopathology , Sinoatrial Node/drug effects , Sinoatrial Node/physiopathology
2.
Eksp Klin Farmakol ; 67(2): 24-6, 2004.
Article in Russian | MEDLINE | ID: mdl-15188755

ABSTRACT

The results of experiments on cats showed that quaternidine, a quaternary ammonium derivative of trimecaine, does not induce significant variations in the hemodynamic parameters, being advantageous in this respect to some well-known antiarrhythmic drugs. LKhT-3-00 (dialkylaminophenylacetamide glutaminate)--a tertiary derivative of lidocaine--leads to a slight decrease in the heart rate, an insignificant decrease in the arterial pressure for 10 min, and a pronounced enhancement of the pumping ability of the left ventricle over a time period of 30 min.


Subject(s)
Anti-Arrhythmia Agents/adverse effects , Hemodynamics/drug effects , Lidocaine/analogs & derivatives , Lidocaine/adverse effects , Quaternary Ammonium Compounds/adverse effects , Trimecaine/adverse effects , Animals , Cats , Female , Male , Trimecaine/analogs & derivatives
3.
Biomed Khim ; 50(5): 502-8, 2004.
Article in Russian | MEDLINE | ID: mdl-15628601

ABSTRACT

On model of experimental diabetes in rats the possibility of correction of impairments of lipid, carbohydrate and albumin metabolism by SEMOP in a dose of 25 or 5 mg/kg, dimephosphone (100 mg/kg) and alpha-tocopherol (25 mg/kg) has been Advantage of SEMOP consists in its ability to decrease a level of total protein and albumin of blood of animals with experimental diabetes.


Subject(s)
Antioxidants/therapeutic use , Diabetes Mellitus, Experimental/drug therapy , Albumins/metabolism , Animals , Carbohydrate Metabolism , Diabetes Mellitus, Experimental/metabolism , Female , Lipid Metabolism , Lipid Peroxidation , Male , Rats
4.
Eksp Klin Farmakol ; 66(5): 22-4, 2003.
Article in Russian | MEDLINE | ID: mdl-14650209

ABSTRACT

The results of experiments on dogs showed that quaternidine, a quaternary ammonium derivative of trimecaine, produces a significant antiarrhythmogenic effect in cases of rhythm disorders in the late stage of a model myocardial infarction. For drugs administered in a single isotoxic dose, the therapeutic effect of quaternidine in animals with acute myocardial ischemia considerably exceeds the duration of action of lidocaine and trimecaine.


Subject(s)
Anti-Arrhythmia Agents/therapeutic use , Quaternary Ammonium Compounds/therapeutic use , Trimecaine/therapeutic use , Ventricular Premature Complexes/drug therapy , Animals , Disease Models, Animal , Dogs , Electrocardiography , Female , Heart Rate/drug effects , Male , Quinidine/therapeutic use , Trimecaine/analogs & derivatives , Ventricular Premature Complexes/physiopathology
5.
Eksp Klin Farmakol ; 66(3): 29-31, 2003.
Article in Russian | MEDLINE | ID: mdl-12924229

ABSTRACT

The results of experiments on cats and dogs showed that quaternidine, a quaternary ammonium derivative of trimecaine, exceeds the structural precursors (trimecaine and lidocaine), as well as the reference drugs quinidine and propranolol, in intensity of the antiarrhythmic action upon single administration on the occlusive and reperfusive arrhythmia models. The therapeutic effect of quaternidine in animals with acute myocardial ischemia lasts for about 8 h, which more than 20 times longer as compared to the duration of action of both lidocaine and trimecaine.


Subject(s)
Anti-Arrhythmia Agents/pharmacology , Arrhythmias, Cardiac/prevention & control , Myocardial Ischemia/complications , Quaternary Ammonium Compounds/pharmacology , Trimecaine/analogs & derivatives , Trimecaine/pharmacology , Animals , Arrhythmias, Cardiac/etiology , Cats , Dogs
6.
Eksp Klin Farmakol ; 65(2): 64-6, 2002.
Article in Russian | MEDLINE | ID: mdl-12109299

ABSTRACT

It is established that galstena possesses hepatoprotector activity and is capable of reducing pathological changes in animals treated with toxic doses of antituberculous drugs. Galstena prevents from the development of cytolysis, as evidence by inhibition of the activity of aspartate aminotransferase, alanine aminotransferase, and lactate dehydrogenase. The anti cholestatic effect of galstena is confirmed by suppression of the growth in the levels of total bilirubin, alkaline phosphatase, and gamma-glutarate transpeptidase. Galstena was also found to possess antiinflammatory properties. Moreover, a growth in the activity of glutathione-dependent reductase (related to inhibited growth of the iron level in the blood serum) is evidence of the antioxidant activity. In addition, galstena prevents from an increase in the content of creatinine and urea, which is evidenced of decreasing endogenous intoxication.


Subject(s)
Antitubercular Agents/adverse effects , Chemical and Drug Induced Liver Injury/drug therapy , Phytotherapy , Plant Extracts/therapeutic use , Animals , Chemical and Drug Induced Liver Injury/blood , Chemical and Drug Induced Liver Injury/etiology , Drug Combinations , Female , Liver/drug effects , Liver/metabolism , Rats
7.
Eksp Klin Farmakol ; 65(1): 41-3, 2002.
Article in Russian | MEDLINE | ID: mdl-12025784

ABSTRACT

The hepatoprotector activity of original compositions of plant origin, containing beet and carrot juices, decoction of dog rose fruits, and extracts of corn silk, peppermint leaves, and common horsetail herbs was studied on an acute hepatitis model induced by tetrachloromethane. An analysis of the data on the hepatocyte cytolysis, cholestasis, lipid peroxidation, and antioxidant system of blood serum showed that the preparations possess membranoprotector and antioxidant properties. This was manifested by a decrease in the activity of alanine aminotransferase and in the levels of total bilirubin and the final (malonaldehyde) and intermediate (diene conjugates) lipid peroxidation products, and by the absence of decline in the level of endogenous alpha-tocopherol and in the activity of glutathione-dependent enzymes.


Subject(s)
Chemical and Drug Induced Liver Injury/prevention & control , Phytotherapy , Plant Preparations/therapeutic use , Protective Agents/therapeutic use , Animals , Carbon Tetrachloride Poisoning/prevention & control , Chemical and Drug Induced Liver Injury/metabolism , Chemical and Drug Induced Liver Injury/pathology , Liver/drug effects , Liver/metabolism , Liver/pathology , Rats , Rats, Wistar
8.
Vopr Med Khim ; 47(6): 593-8, 2001.
Article in Russian | MEDLINE | ID: mdl-11925749

ABSTRACT

The influence of the original vegetable complexes (which include: juices of beet-rout and carrot, decoction of degrose berries, extracts of corn silk, leaves of peppermint and some other components) on the indicators of the cytolysis, lipid peroxidation and antioxidant system of serum of the laboratory rats with acute toxic hepatitis, was investigated. The vegetable complexes exhibited antioxidant effects which were proved by the reduction of the final and intermediate products of lipoperoxidization, the absence of decline of the level of endogenous alpha-tocopherol content and glutathione dependent enzymes.


Subject(s)
Antioxidants/therapeutic use , Chemical and Drug Induced Liver Injury/drug therapy , Phytotherapy , Plant Preparations/therapeutic use , Acute Disease , Animals , Carbon Tetrachloride Poisoning/drug therapy , Carbon Tetrachloride Poisoning/metabolism , Chemical and Drug Induced Liver Injury/metabolism , Lipid Peroxidation , Male , Rats , Rats, Wistar
9.
Eksp Klin Farmakol ; 62(2): 22-4, 1999.
Article in Russian | MEDLINE | ID: mdl-10340123

ABSTRACT

Experiments were conducted on models of early occlusion and reperfusion arrhythmias in cats to study the antiarrhythmic activity of trimecain, its morpholine analogue (MPT), and MPT derivatives containing glycine, magnesium salt of aspartic acid, and N-acetylglutaminic acid. All the compounds were injected in doses of 5% of LD50. A 22.5 mg/kg dose of trimecain prevented cardiac rhythm disorders after occlusion of the coronary arteries as well as after restoration of the coronary blood flow. Replacement of the diethyl group in the structure of trimecain by the morpholine ring led to diminution of antiarrhythmic activity, and MPT in a dose of 28.0 mg/kg, in distinction from the former, had no effect on the frequency of the occurrence of early occlusion arrhythmias and the duration of reperfusion arrhythmias. Introduction of amino acids as an anion into the MPT structure raised the antiarrhythmic activity of the last named.


Subject(s)
Amino Acids/therapeutic use , Anti-Arrhythmia Agents/therapeutic use , Arrhythmias, Cardiac/drug therapy , Myocardial Ischemia/complications , Myocardial Reperfusion Injury/complications , Trimecaine/analogs & derivatives , Trimecaine/therapeutic use , Animals , Arrhythmias, Cardiac/etiology , Cats , Chi-Square Distribution , Disease Models, Animal , Drug Evaluation, Preclinical , Structure-Activity Relationship , Time Factors
12.
Eksp Klin Farmakol ; 60(1): 65-7, 1997.
Article in Russian | MEDLINE | ID: mdl-9162291

ABSTRACT

It was shown in rabbit experiments that the use of ximedon in long-term immobilization stress limits activation of lipid peroxidation, stimulates the main enzymes of the antioxidant systems, causes of hypolipidemic, preventive endotheliotropic, and cardiotropic effect.


Subject(s)
Adaptation, Physiological/drug effects , Pyrimidines/pharmacology , Stress, Psychological/drug therapy , Animals , Chronic Disease , Drug Evaluation, Preclinical , Lipid Peroxidation/drug effects , Male , Pyrimidines/therapeutic use , Rabbits , Restraint, Physical , Stress, Psychological/blood , Stress, Psychological/physiopathology , Time Factors
15.
Patol Fiziol Eksp Ter ; (2): 22-4, 1996.
Article in Russian | MEDLINE | ID: mdl-8754140

ABSTRACT

The rabbit experiment has studied the impact of ultraviolet (UV) blood irradiation on the course of adaptative processes under restrictive stress. Thirty-day hypodynamia was demonstrated to result in chronic stress whose pathogenetic links are activated neutrophilic leukocytes, developed disseminated intravascular coagulation, atherogenic metabolic changes. UV blood irradiation enhanced the body's adaptative potentialities under long-term hypodynamia, by diminishing restriction-induced stress lesion.


Subject(s)
Adaptation, Physiological/radiation effects , Hypokinesia/blood , Ultraviolet Rays , Animals , Blood/radiation effects , Male , Rabbits
16.
Eksp Klin Farmakol ; 59(2): 17-9, 1996.
Article in Russian | MEDLINE | ID: mdl-8974556

ABSTRACT

The protective effects of fructose-1, 6-diphosphate, sodium malate and cytochrome C were studied in the experiments on rats with disorders of the cardiac rhythm of various origin. The compounds studied prevent the strophantine and adrenaline-induced cardiac rhythm disturbances, but appeared ineffective on aconitine and calcium chloride models.


Subject(s)
Anti-Arrhythmia Agents/therapeutic use , Energy Metabolism/drug effects , Animals , Arrhythmias, Cardiac/chemically induced , Arrhythmias, Cardiac/drug therapy , Arrhythmias, Cardiac/metabolism , Disease Models, Animal , Drug Evaluation, Preclinical , Myocardial Ischemia/drug therapy , Myocardial Ischemia/metabolism , Rats , Rats, Wistar
SELECTION OF CITATIONS
SEARCH DETAIL
...